anonymous
Guest
anonymous
Guest
The good news is they didn't go after both Eliquis and Opdivo. After reading Boehner's email I am not certain the company is confident in the future after 2026.
moronThe good news is they didn't go after both Eliquis and Opdivo. After reading Boehner's email I am not certain the company is confident in the future after 2026.